Edwards Lifesciences acquires the remaining 48% stake in Vectorious Medical at a $497 million valuation after previously acquiring 52% in 2023. Vectorious is an Israeli company that develops devices to treat heart disease.
image sourced from original article at https://en.globes.co.il/en/article-edwards-buys-48-stake-in-vectorious-medical-at-497m-valuation-1001520771Original article source: https://en.globes.co.il/en/article-edwards-buys-48-stake-in-vectorious-medical-at-497m-valuation-1001520771
Source Id: 8846837113
